Accidental Synthetic Cannabinoid Poisoning in a Pediatric Patient: A Case Report

Andrew J Gonedes1, Eric Boccio1

  • 1Emergency Medicine, Memorial Healthcare System, Hollywood, USA.

Cureus
|January 2, 2025
PubMed

Insights

Accidental ingestion of synthetic cannabinoid edibles by a child led to lethargy and altered mental status. Supportive care resulted in full recovery, highlighting risks of pediatric cannabis exposure.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Toxicology

Background:

  • Increasing prevalence of accidental pediatric exposure to cannabis-derived products.
  • Edible formulations pose a risk due to delayed onset and higher potency.

Observation:

  • A six-year-old boy presented with lethargy, altered mental status, and increased muscle tone after ingesting a synthetic cannabinoid edible.
  • Initial assessment revealed sinus tachycardia with a prolonged QTc interval.
  • Toxicology screening was positive for cannabinoids.

Findings:

  • The child received supportive care for synthetic cannabinoid toxicity.
  • Management focused on airway protection and monitoring vital signs.
  • The patient experienced a full recovery without neurological deficits.

Implications:

  • Highlights the need for increased awareness and education on safe storage of cannabis products.
  • Underscores the importance of prompt medical evaluation for suspected pediatric cannabinoid ingestion.
  • Informs clinical management strategies for synthetic cannabinoid exposures in children.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
184
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
131
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
126